Pharming Group N.V.: Pharming Group reports financial results for the first half of 2022
Total revenues increased 4% in H1 2022 to US$96.8 million, supported by increases in physicians prescribing and number of patients Strong balance sheet and stable cash flow from RUCONEST providing